In multiple myeloma following are seen -(
## Core Concept
Multiple myeloma is a type of hematological malignancy characterized by the proliferation of malignant plasma cells in the bone marrow. This condition leads to various clinical manifestations due to the overproduction of monoclonal immunoglobulins (M-protein), marrow failure, and bone destruction. Understanding the pathophysiology and clinical features of multiple myeloma is crucial for diagnosing and managing the disease.
## Why the Correct Answer is Right
The correct answer, , likely corresponds to a set of clinical or laboratory features commonly associated with multiple myeloma. Typically, multiple myeloma presents with anemia, bone pain (often back pain), renal impairment, and an increased risk of infections. Laboratory findings may include a monoclonal spike on serum protein electrophoresis (SPEP) or urine protein electrophoresis (UPEP), lytic bone lesions on radiographs, and specific abnormalities on bone marrow biopsy.
## Why Each Wrong Option is Incorrect
- **Option A:** Without specific details on what represents, it's challenging to directly refute its relevance to multiple myeloma. However, if does not align with established diagnostic criteria, clinical manifestations, or common laboratory findings in multiple myeloma, it would be considered incorrect.
- **Option B:** Similarly, if does not correspond to known features of multiple myeloma, such as hypercalcemia due to bone destruction, anemia, or renal failure, it would not be accurate.
- **Option C:** This option might be incorrect if it suggests features not typically associated with multiple myeloma or if it omits critical aspects of the disease.
## Clinical Pearl / High-Yield Fact
A key clinical pearl in the context of multiple myeloma is the CRAB criteria, which are used to diagnose the disease: **C** (Calcium elevation), **R** (Renal failure), **A** (Anemia), and **B** (Bone lesions). The presence of any one of these features, in conjunction with a monoclonal plasma protein (M-protein) in the serum or urine and/or clonality on bone marrow biopsy, supports the diagnosis of multiple myeloma.
## Correct Answer: .